These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 9285100

  • 1. Interaction of eukaryotic initiation factor 5A with the human immunodeficiency virus type 1 Rev response element RNA and U6 snRNA requires deoxyhypusine or hypusine modification.
    Liu YP, Nemeroff M, Yan YP, Chen KY.
    Biol Signals; 1997; 6(3):166-74. PubMed ID: 9285100
    [Abstract] [Full Text] [Related]

  • 2. Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation.
    Park MH, Wolff EC, Folk JE.
    Biofactors; 1993 May; 4(2):95-104. PubMed ID: 8347280
    [Abstract] [Full Text] [Related]

  • 3. Hypusine is required for a sequence-specific interaction of eukaryotic initiation factor 5A with postsystematic evolution of ligands by exponential enrichment RNA.
    Xu A, Chen KY.
    J Biol Chem; 2001 Jan 26; 276(4):2555-61. PubMed ID: 11060315
    [Abstract] [Full Text] [Related]

  • 4. Effects of translation initiation factor eIF-5A on the functioning of human T-cell leukemia virus type I Rex and human immunodeficiency virus Rev inhibited trans dominantly by a Rex mutant deficient in RNA binding.
    Katahira J, Ishizaki T, Sakai H, Adachi A, Yamamoto K, Shida H.
    J Virol; 1995 May 26; 69(5):3125-33. PubMed ID: 7707541
    [Abstract] [Full Text] [Related]

  • 5. Eukaryotic initiation factor 5A activity and HIV-1 Rev function.
    Bevec D, Hauber J.
    Biol Signals; 1997 May 26; 6(3):124-33. PubMed ID: 9285095
    [Abstract] [Full Text] [Related]

  • 6. Marked elevation of hypusine formation activity on eukaryotic initiation factor 5A in v-HA-RAS transformed mouse NIH3T3 cells.
    Chen ZP, Chen KY.
    Cancer Lett; 1997 May 19; 115(2):235-41. PubMed ID: 9149130
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the activities of variant forms of eIF-4D. The requirement for hypusine or deoxyhypusine.
    Park MH, Wolff EC, Smit-McBride Z, Hershey JW, Folk JE.
    J Biol Chem; 1991 May 05; 266(13):7988-94. PubMed ID: 1850732
    [Abstract] [Full Text] [Related]

  • 8. Structural features of the eIF-5A precursor required for posttranslational synthesis of deoxyhypusine.
    Joe YA, Park MH.
    J Biol Chem; 1994 Oct 14; 269(41):25916-21. PubMed ID: 7929297
    [Abstract] [Full Text] [Related]

  • 9. Cofactor requirements for nuclear export of Rev response element (RRE)- and constitutive transport element (CTE)-containing retroviral RNAs. An unexpected role for actin.
    Hofmann W, Reichart B, Ewald A, Müller E, Schmitt I, Stauber RH, Lottspeich F, Jockusch BM, Scheer U, Hauber J, Dabauvalle MC.
    J Cell Biol; 2001 Mar 05; 152(5):895-910. PubMed ID: 11238447
    [Abstract] [Full Text] [Related]

  • 10. Identification of mRNA that binds to eukaryotic initiation factor 5A by affinity co-purification and differential display.
    Xu A, Jao DL, Chen KY.
    Biochem J; 2004 Dec 15; 384(Pt 3):585-90. PubMed ID: 15303967
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A.
    Bevec D, Jaksche H, Oft M, Wöhl T, Himmelspach M, Pacher A, Schebesta M, Koettnitz K, Dobrovnik M, Csonga R, Lottspeich F, Hauber J.
    Science; 1996 Mar 29; 271(5257):1858-60. PubMed ID: 8596953
    [Abstract] [Full Text] [Related]

  • 12. Effects of inhibitors of RNA and protein synthesis on the subcellular distribution of the eukaryotic translation initiation factor, eIF-5A, and the HIV-1 Rev protein.
    Shi XP, Yin KC, Waxman L.
    Biol Signals; 1997 Mar 29; 6(3):143-9. PubMed ID: 9285097
    [Abstract] [Full Text] [Related]

  • 13. Interaction of the HIV-1 rev cofactor eukaryotic initiation factor 5A with ribosomal protein L5.
    Schatz O, Oft M, Dascher C, Schebesta M, Rosorius O, Jaksche H, Dobrovnik M, Bevec D, Hauber J.
    Proc Natl Acad Sci U S A; 1998 Feb 17; 95(4):1607-12. PubMed ID: 9465063
    [Abstract] [Full Text] [Related]

  • 14. Subcellular localization of the hypusine-containing eukaryotic initiation factor 5A by immunofluorescent staining and green fluorescent protein tagging.
    Jao DL, Yu Chen K.
    J Cell Biochem; 2002 Feb 17; 86(3):590-600. PubMed ID: 12210765
    [Abstract] [Full Text] [Related]

  • 15. Hypusine is essential for eukaryotic cell proliferation.
    Park MH, Lee YB, Joe YA.
    Biol Signals; 1997 Feb 17; 6(3):115-23. PubMed ID: 9285094
    [Abstract] [Full Text] [Related]

  • 16. Dramatic attenuation of hypusine formation on eukaryotic initiation factor 5A during senescence of IMR-90 human diploid fibroblasts.
    Chen ZP, Chen KY.
    J Cell Physiol; 1997 Mar 17; 170(3):248-54. PubMed ID: 9066781
    [Abstract] [Full Text] [Related]

  • 17. The role of hypusine depletion in cytostasis induced by S-adenosyl-L-methionine decarboxylase inhibition: new evidence provided by 1-methylspermidine and 1,12-dimethylspermine.
    Byers TL, Lakanen JR, Coward JK, Pegg AE.
    Biochem J; 1994 Oct 15; 303 ( Pt 2)(Pt 2):363-8. PubMed ID: 7980394
    [Abstract] [Full Text] [Related]

  • 18. Biological Relevance and Therapeutic Potential of the Hypusine Modification System.
    Pällmann N, Braig M, Sievert H, Preukschas M, Hermans-Borgmeyer I, Schweizer M, Nagel CH, Neumann M, Wild P, Haralambieva E, Hagel C, Bokemeyer C, Hauber J, Balabanov S.
    J Biol Chem; 2015 Jul 24; 290(30):18343-60. PubMed ID: 26037925
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.